A Study Comparing SB4 to Enbrel® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy

NCT01895309 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

596

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Enbrel (etanercept)
DRUG: SB4 (proposed biosimilar to etanercept)

Sponsor

Samsung Bioepis Co., Ltd.